MITO Annual Cash & Cash Equivalents
$47.13 M
+$14.35 M+43.76%
31 December 2021
Summary:
As of January 23, 2025, MITO annual cash & cash equivalents is $47.13 million, with the most recent change of +$14.35 million (+43.76%) on December 31, 2021. During the last 3 years, it has risen by +$36.28 million (+334.22%).MITO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MITO Quarterly Cash And Cash Equivalents
$33.83 M
-$13.30 M-28.22%
31 March 2022
Summary:
As of January 23, 2025, MITO quarterly cash and cash equivalents is $33.83 million, with the most recent change of -$13.30 million (-28.22%) on March 31, 2022. Over the past year, it has increased by +$1.77 million (+5.53%).MITO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MITO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.8% | +5.5% |
| 3 y3 years | +334.2% | -52.0% |
| 5 y5 years | +1044.4% | +721.5% |
MITO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -7.2% | -52.0% |
Stealth BioTherapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $33.83 M(-28.2%) |
| Dec 2021 | $47.13 M(+43.8%) | $47.13 M(+11.5%) |
| Sept 2021 | - | $42.28 M(+37.4%) |
| June 2021 | - | $30.77 M(-4.0%) |
| Mar 2021 | - | $32.06 M(-2.2%) |
| Dec 2020 | $32.79 M | $32.79 M(+64.8%) |
| Sept 2020 | - | $19.89 M(-37.5%) |
| June 2020 | - | $31.83 M(+1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $31.24 M(-38.5%) |
| Dec 2019 | $50.77 M(+367.7%) | $50.77 M(+36.4%) |
| Sept 2019 | - | $37.23 M(-30.0%) |
| June 2019 | - | $53.20 M(-24.5%) |
| Mar 2019 | - | $70.50 M(+549.4%) |
| Dec 2018 | $10.86 M(+163.5%) | $10.86 M(+166.2%) |
| Sept 2018 | - | $4.08 M(-1.0%) |
| Dec 2017 | $4.12 M(-57.6%) | $4.12 M |
| Dec 2016 | $9.71 M | - |
FAQ
- What is Stealth BioTherapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Stealth BioTherapeutics?
- What is Stealth BioTherapeutics annual cash & cash equivalents year-on-year change?
- What is Stealth BioTherapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Stealth BioTherapeutics?
- What is Stealth BioTherapeutics quarterly cash and cash equivalents year-on-year change?
What is Stealth BioTherapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of MITO is $47.13 M
What is the all time high annual cash & cash equivalents for Stealth BioTherapeutics?
Stealth BioTherapeutics all-time high annual cash & cash equivalents is $50.77 M
What is Stealth BioTherapeutics annual cash & cash equivalents year-on-year change?
Over the past year, MITO annual cash & cash equivalents has changed by +$14.35 M (+43.76%)
What is Stealth BioTherapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MITO is $33.83 M
What is the all time high quarterly cash and cash equivalents for Stealth BioTherapeutics?
Stealth BioTherapeutics all-time high quarterly cash and cash equivalents is $70.50 M
What is Stealth BioTherapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, MITO quarterly cash and cash equivalents has changed by +$1.77 M (+5.53%)